Heart Valve Technology

This channel includes news and new device innovations about heart valve technologies, including the aortic valve, mitral valve, pulmonic valve, and tricuspid valve. This includes information on transcatheter valve technologies like transcatheter aortic valve replacement (TAVR, or implantation TAVI), transcatheter mitral valve repair or replacement (TMVR), transcatheter and surgical valve repairs, and surgical replacement valves. Newer devices are now being used for transcatheter tricuspid valve repair replacement (TTVR).

This study was evaluating 30-days and 1-year safety and performance of the Hydra transcatheter aortic heart valve in the treatment of symptomatic severe aortic stenosis in cardiac patients at high or extremely high surgical risk.

News | Heart Valve Technology

SMT announces positive results of Hydra Transcatheter Aortic Heart Valve published in JACC

February 14, 2022 — SMT (Sahajanand Medical Technologies Limited) has announced the publication of Hydra Transcatheter ...

February 14, 2022

The Cardiovalve transcatheter mitral valve replacement (TMVR) technology for patients suffering from mitral or tricuspid regurgitation (MR and TR), is undergoing clinical trials in Europe.

News | Structural Heart

Technology Incubator Peregrine Ventures Exits Transcatheter Valve Company Cardiovalve

January 18, 2022 — Peregrine Ventures, a leading investment firm dedicated to supporting life changing healthcare ...

January 18, 2022

The Tria biopolymer surgical aortic valve displayed at Beaumont Hospital, Royal Oak.

News | Heart Valve Technology

Foldax Gets Indian Approval to Start Clinical Trial of Tria Biopolymer Surgical Aortic Valve

December 13, 2021 - Foldax Inc. announced that the Drugs Controller General of India (DCGI), India’s regulatory body for ...

December 13, 2021

Videos | Cardiovascular Ultrasound

VIDEO: New Echo Technology to Aid Structural Heart Interventions

Examples of TrueView and GlassView 3D cardiac ultrasound visualization and artificial intelligence (AI) assisted ...

November 24, 2021

News | Structural Heart

Atlantic Health System’s Morristown Medical Center Randomizes First Patient in World to New Study to Evaluate Treatment with TAVR for Moderate Aortic Stenosis

November 22, 2021 — Atlantic Health System’s Morristown Medical Center announced that it has enrolled the first patient ...

November 22, 2021

Repair of Tricuspid Valve Leak CTCR-MVS - Evaluating the Benefit of Concomitant Tricuspid Repair During Mitral Valve Surgery.

News | Structural Heart

Repair of Tricuspid Valve Leak During Mitral Valve Surgery May Benefit Some Adults

November 18, 2021 — Adults undergoing mitral valve surgery who have less than severe leakage of the tricuspid valve may ...

November 18, 2021

News | Structural Heart

Surgery to Replace Heart Valve Beneficial Even With No Symptoms of Severe Aortic Stenosis

November 17, 2021 — For people experiencing severe aortic stenosis who do not have symptoms or need symptom relief ...

November 17, 2021

Medtronic Apollo Intrepid TMVR is currently in the middle of a U.S. clinical trial. #TCT #TCT21 #TMVR

News | Structural Heart

Medtronic Intrepid Transcatheter Mitral Valve Successfully Uses Transfemoral Delivery

November 10, 2021 — Medtronic presented early data for its self-expanding Intrepid transcatheter mitral valve ...

November 10, 2021

TCT 2021 Announces Late-Breaking Clinical Trials

Feature | TCT

Links to all the TCT 2021 Late-Breaking Clinical Trials

November 10, 2021 — There were nine late-breaking trials and 13 late-breaking science presentations at the 2021 Transcat ...

November 10, 2021

The Teleflex Manta large bore vascular closure device #TCT2021

News | Vascular Closure Devices

Plug-based Vascular Closure Following TAVR Offers Shorter Hemostasis Time Than Suture-based Devices

November 9, 2021 — Results from the largest randomized trial available comparing different closure device strategies ...

November 09, 2021

TAVR CT image reconstruction of an implanted Medtronic CoreValve. #TCT21 #TCT #TAVR #SURTAVI

News | Heart Valve Technology

Intermediate-risk Patients Have Similar Five-year Outcomes With Transcatheter or Surgical Aortic Valve Replacement

November 9, 2021 — New five-year data from the SURTAVI trial found that there was no difference in all-cause mortality ...

November 09, 2021

A PARTNER 3 trial economic analysis shows for low surgical risk patients, TAVR is cost-saving compared with SAVR. TAVR Sapien Valve visualized using a GE guidance software. #TCT2021

News | Structural Heart

TAVR Is Cost Effective Compared With Surgical Replacement for Low-risk Patients

November 9, 2021 — An economic analysis of data from PARTNER 3, a randomized trial comparing transcatheter aortic valve ...

November 09, 2021

The Edwards Lifesciences Evoque transcatheter tricuspid valve replacement system demonstrated sustained favorable patient outcomes at six months in the TRISCEND study.

News | Structural Heart

Six-Month Outcomes Positive for Transfemoral Tricuspid Valve in Tricuspid Regurgitation Patients

November 8, 2021 — Results from a clinical trial of the Edwards Lifesciences Evoque transcatheter tricuspid valve ...

November 08, 2021

The FDA cleared the world's first photon-counting computed tomography (CT) scanner, the Siemens Naeotom Alpha, in late September. This new technology will likely change the future direction of CT. Biosense Webster also announced the first cases using its Heliostar radiofrequency balloon ablation catheter were completed in September. Both were among the top stories in October.

Feature | By Dave Fornell, DAIC Editor

November 1, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

November 01, 2021

Videos | Structural Heart

VIDEO: Abbott Structural Heart CMO Shares Views on Future of Valve Interventions

Dr. Neil Moat, MBBS, chief medical officer of Abbott's structural heart business, was a cardiac surgeon specializing in ...

October 15, 2021